EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS ‐Mediated Carcinogenesis

Shigenori Suzuki, Hiroaki Hase, Yosuke Inomata iD, Jun Arima, Kentaro Jingushi iD, Atsushi Tomioka, Nao Kawaguchi iD, Hiroki Hamamoto, Ryo Tanaka, Yoshiro Imai, Mitsuhiro Asakuma, Tomohito Tanaka iD und 3 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Shigenori Suzuki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan. Hauptthemen laut MEDLINE: Polypyrimidine Tract-Binding Protein, MicroRNAs, Pancreatic Neoplasms, Heterogeneous-Nuclear Ribonucleoproteins. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polypyrimidine tract‐binding protein 1, an alternative splicing factor, drives cancer‐associated metabolic reprogramming by modulating pyruvate kinase M splicing. Although organ‐abundant microRNAs (miRs) regulate this protein, its role in tumor progression remains unclear. Therefore, we investigated the functional relationship between polypyrimidine tract‐binding protein 1‐associated microRNAs and this protein in pancreatic cancer to identify pancreas‐enriched microRNAs and explore polypyrimidine tract‐binding protein 1 function beyond metabolic regulation. The expression of miR‐216b‐5p, which is typically pancreas‐enriched, was significantly downregulated in clinical pancreatic cancer samples, whereas polypyrimidine tract‐binding protein 1 expression was markedly upregulated. Mechanistically, miR‐216b‐5p directly binds to the 3′ UTR of polypyrimidine tract‐binding protein 1 mRNA, thereby suppressing its expression and inhibiting cancer cell proliferation. Proteomic analysis, integrated with publicly available individual‐nucleotide resolution UV crosslinking and immunoprecipitation data, identified thymidylate synthase as a novel downstream target of polypyrimidine tract‐binding protein 1, likely regulated via splicing‐related RNA‐level mechanisms. Thymidylate synthase expression was also elevated in pancreatic cancer tissues and correlated with poor prognosis. Functional assays revealed that polypyrimidine tract‐binding protein 1 and thymidylate synthase silencing induced cell cycle arrest. Our findings uncover a previously unrecognized miR‐216b‐5p/polypyrimidine tract‐binding protein 1/thymidylate synthase regulatory axis that promotes pancreatic cancer progression and establish polypyrimidine tract‐binding protein 1 as a central molecular regulator of tumor biology beyond its metabolic role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polypyrimidine Tract-Binding ProteinMicroRNAsPancreatic NeoplasmsHeterogeneous-Nuclear RibonucleoproteinsThymidylate SynthaseCarcinogenesisHumansGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationAnimals3' Untranslated Regions

Stichwörter der Autor:innen

alternative splicingmicroRNApancreatic cancerpolypyrimidine tract‐binding protein 1thymidylate synthase

Substanzen

Polypyrimidine Tract-Binding ProteinMicroRNAsHeterogeneous-Nuclear RibonucleoproteinsPTBP1 protein, humanThymidylate SynthaseTYMS protein, humanMIRN216 microRNA, human3' Untranslated Regions

Autor:innen und Institutionen

  • Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Laboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Osaka, Japan.
  • Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Compound Library Screening Center, Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Osaka, Japan.

ORCID-Profile: Yosuke Inomata, Kentaro Jingushi, Nao Kawaguchi, Tomohito Tanaka, Kohei Taniguchi

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Suzuki, S., Hase, H., Inomata, Y., Arima, J., Jingushi, K., Tomioka, A., Kawaguchi, N., Hamamoto, H., Tanaka, R., Imai, Y., Asakuma, M., Tanaka, T., Tsujikawa, K., Taniguchi, K., & Lee, S. W. (2026). Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS ‐Mediated Carcinogenesis. Cancer Science. https://doi.org/10.1111/cas.70402

Vancouver

Suzuki S, Hase H, Inomata Y, Arima J, Jingushi K, Tomioka A, et al. Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS ‐Mediated Carcinogenesis. Cancer Science. 2026. doi:10.1111/cas.70402

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Shigenori and Hase, Hiroaki and Inomata, Yosuke and Arima, Jun and Jingushi, Kentaro and Tomioka, Atsushi and Kawaguchi, Nao and Hamamoto, Hiroki and Tanaka, Ryo and Imai, Yoshiro and Asakuma, Mitsuhiro and Tanaka, Tomohito and Tsujikawa, Kazutake and Taniguchi, Kohei and Lee, Sang-Woong},
  title = {Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS ‐Mediated Carcinogenesis},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70402}
}
Kostenlos starten →